Brind.
  1. Leading pharmaceutical companies including Novartis, Eli Lilly, Pfizer, and Bristol Myers Squibb are focused on cutting-edge oncology approaches amid projections of 2 million new cancer cases in the US.

The projected rise in cancer diagnoses involves the American Cancer Society and Calidi Biotherapeutics.

4 reports, 1 independent Updated Jul 10
Gone quiet
Reports
4
Developments
2
Repetition
50%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

The projected rise in cancer diagnoses involves the American Cancer Society and Calidi Biotherapeutics.

Who's involved

What this event is mainly about
American Cancer Society

How it developed

Newest first. Tap a step to see who reported it.
  1. Projected rise in cancer diagnoses involving ACS and Calidi Biotherapeutics.1 source
  2. Calidi addresses unmet needs based on ACS projections regarding cancer.

Keep exploring

Part of

Leading pharmaceutical companies including Novartis, Eli Lilly, Pfizer, and Bristol Myers Squibb are focused on cutting-edge oncology approaches amid projections of 2 million new cancer cases in the US. All 1 developments

The entities involved

Related events

Coverage

Newest first; wire copies grouped
  • GlobeNewswireCalidi Biotherapeutics Inc. (NYSE American: CLDI) Platform Designed to Transform Landscape of Cancer Treatment NEW YORK, July 10, 2025 (GLOBE NEWSWIRE) -- via InvestorWire — Calidi Biotherapeutics In
  • Unknown outlet
  • Unknown outlet
  • Unknown outlet